Literature DB >> 29849665

Evaluating Malaria Prevalence Using Clinical Diagnosis Compared with Microscopy and Rapid Diagnostic Tests in a Tertiary Healthcare Facility in Rivers State, Nigeria.

M N Wogu1, F O Nduka1.   

Abstract

The World Health Organization's policy on laboratory test of all suspected malaria cases before treatment has not yielded significant effects in several rural areas of Sub-Saharan Africa due to inadequate diagnostic infrastructure, leading to high morbidity and mortality rates. A cross-sectional randomized study was conducted to evaluate the validity of clinical malaria diagnosis through comparison with microscopy and rapid diagnostic test kits (RDTs) using 1000 consenting outpatients of a tertiary hospital in Nigeria. Physicians conducted clinical diagnosis, and blood samples were collected through venous procedure and analyzed for malaria parasites using Giemsa microscopy and RDT kits. Microscopy was considered the diagnostic "gold standard" and all data obtained were statistically analyzed using Chi-square test with a P value <0.05 considered significant. Malaria prevalence values of 20.1%, 43.1%, and 29.7% were obtained for clinical diagnosis, microscopy, and RDTs, respectively (P < 0.05). Values of 47.2%, 95.9%, and 77.8% were obtained for sensitivity, specificity, and diagnostic accuracy, respectively, in clinical diagnosis, while RDTs had sensitivity, specificity, and diagnostic accuracy values of 73.7%, 97.3%, and 88.3%, respectively, when compared to microscopy (P < 0.05). Clinical diagnosed malaria cases should be confirmed with a parasite-based laboratory diagnosis and more qualitative research is needed to explore why clinicians still use clinical diagnosis despite reported cases of its ineffectiveness.

Entities:  

Year:  2018        PMID: 29849665      PMCID: PMC5937386          DOI: 10.1155/2018/3954717

Source DB:  PubMed          Journal:  J Trop Med        ISSN: 1687-9686


1. Introduction

Malaria infection causes high levels of morbidity and mortality in Sub-Saharan Africa especially Nigeria [1]. The World Health Organization (WHO) previously advised presumptive diagnosis as the basis for the first-line treatment of uncomplicated malaria in places where a parasitological test is not possible [1]. This policy allowed uncomplicated malaria illness to be treated by village health workers, shop keepers, and relatives in the home and thus minimizes delays in treatment, especially for those living a long distance from formal healthcare facilities. In most regions in Africa, over 70% of individuals with symptomatic malaria do not initially seek medical assistance from healthcare facilities but are self-diagnosed and receive treatments at home with either traditional medications or antimalarial drugs purchased from local chemists or drug shops [2]. Such symptomatic malaria individuals only seek further treatment in health facilities when self-medications with traditional or orthodox drugs fail and this has a negative effect on the performance of some malaria diagnostic techniques as well as treatment [3]. The signs and symptoms as well as physical examination of the patients by physicians play a key role in clinical diagnosis because clinical diagnosis is still used for therapeutic care of most febrile individuals by physicians in several malaria endemic regions despite some reported cases of its imprecision. Improving the diagnosis of malaria so that therapeutic care is given to only patients who require it is a public health priority in Africa especially Nigeria. Early malaria symptoms vary and are not malaria-specific; they include high fever, headache, general body weakness, recurrent chills, dizziness, abdominal cramps, diarrhoea, nausea bouts, vomiting, and loss of appetite. Other common but equally life threatening infections such as febrile ailments and viral and bacterial infections possess similar signs and symptoms to malaria; hence, clinical diagnosis is quite challenging and unreliable [4]. The signs and symptoms of malaria and other tropical diseases overlap, and this hinders the rate of diagnostic specificity and sensitivity, thereby increasing the wrong use of antimalarial drugs and reduction in the effective management of patients with nonmalarial febrile illness especially in malaria endemic regions [4-6]. Healthcare providers with little diagnostic training in developing countries that also lack adequate laboratory diagnostic equipment have been able to manage and diagnose most childhood diseases due to the clinical algorithms created by the Integrated Management of Children Illness (IMCI) [6]. In an African region, a commonly used clinical algorithm for malaria diagnosis when compared with a fully trained paediatrician with full access to adequate laboratory diagnostic equipment showed a very low specificity rate of 0–9% but a high sensitivity rate of 100% [7, 8]. The low specificity rate shows the diagnostic challenge of differentiating malaria from other types of fever in children based on only presumptive diagnosis. Hence, efficient malaria diagnosis is achieved by using both presumptive and laboratory based (identification of the parasite) diagnosis [9]. The World Health Organization currently recommends that all suspected cases of malaria must undergo laboratory parasite-based diagnosis (e.g., using microscopy and rapid diagnostic test kits) before treatment due to inadequate information on the effectiveness of presumptive diagnosis. This study was conducted to investigate the validity of clinical diagnosis by physicians as an effective malaria diagnostic technique when compared with microscopy and rapid diagnostic test kits in a tertiary hospital in Rivers State, Nigeria.

2. Materials and Methods

2.1. Study Area and Population

The study was conducted in Port Harcourt, Rivers State. Port Harcourt is the capital of Rivers State, it lies along the Bonny River in the Niger, Delta region of Nigeria, temperature throughout the year is relatively constant (25°C–28°C), relative humidity fluctuates between 90 and 100%, and it is geographically located at latitude 4.75°N and longitude 7.00°E [10]. A total of 1000 consenting study subjects (irrespective of age and sex) attending the Outpatient Department of University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, were recruited for the study. Ethical clearance was obtained from the Rivers State Ministry of Health and the University of Port Harcourt Teaching Hospital before the commencement of this study. The inclusion criteria for this study were that study participants had suspected body temperatures ≥ 38°C for less than 10 days, were examined by a physician, and gave their oral or written consent (consent was obtained from the parents or guardians of participants below 18 years) to be part of the research. Exclusion criteria included individuals undergoing malarial treatment (or took antimalarial drugs within two weeks before the research), those diagnosed with mental illness, measles, chickenpox, infected wounds, and pneumonia, and those with suspected body temperatures ≥38°C by physicians but did not give their consent to be part of the study.

2.2. Data Collection

Clinical diagnosis was conducted by physicians. Blood samples were collected through venous procedure by trained laboratory scientists and stored in Ethylene Diamine Tetra Acetate (EDTA) tubes to prevent coagulation. From the collected blood samples, blood films (thick and thin) were prepared, stained (using Giemsa stain), and examined microscopically using established laboratory procedures [11]. Thick blood films were used to estimate the level of parasitaemia by counting the number of parasites against 200 white blood cells with the assumption that each subject had 8,000 white blood cells/μL of blood. A minimum of 200 fields were examined before declaring slides negative for malaria parasite. The RDT kit used was CareStart™ malaria HRP2/pLDH Pf Test Kit (Access Bio Inc., USA) and the usage was according to the manufacturer's instructions. For quality assurance when conducting microscopy, two trained microscopists viewed each blood film before declaring the slide positive or negative but when conflicting results arose, a third senior microscopist was used. The RDT kits were stored at the manufacturer's recommended temperature (<40°C) and quality control and the validity of each kit used was certified by several laboratory scientists. Data accuracy was ascertained by double entry of all data obtained.

2.3. Data Analysis

The data obtained for clinical diagnosis were compared with those for RDT using microscopy as the gold standard to evaluate sensitivity, specificity, diagnostic accuracy, positive predictive value, and negative predictive value using true positives, true negatives, false positives, and false negatives. Data generated were analyzed using Chi-square test and a P value less than 0.05 was considered significant.

3. Results

Plasmodium falciparum was the only species of malaria parasite identified with confirmation from polymerase chain reaction technique (PCR). Prevalence values of 20.1%, 43.1%, and 29.7% obtained for clinical diagnosis, microscopy, and RDTs, respectively (P < 0.05) (Table 1). Using microscopy as the diagnostic standard, clinical diagnosis had value of 47.2%, 95.9%, and 77.8% for sensitivity, specificity, and diagnostic accuracy, respectively, while RDT had sensitivity, specificity, and diagnostic accuracy values of 73.7%, 97.3%, and 88.3%, respectively (P < 0.05) (Table 2).
Table 1

Malaria prevalence in relation to diagnostic techniques.

Diagnostic techniquesNumber examinedNumber infected (%)
Clinical diagnosis1000201 (20.1)
Microscopy1000431 (43.1)
RDTs1000297 (29.7)

X 2 = 124.855, Df = 2, and P value = 0.001 (P < 0.05).

Table 2

Diagnostic efficiency of presumptive diagnosis and RDTs using microscopy as a standard.

Diagnostic techniquesDiagnostic parameters (%)
SNSPDAPPVNPV
Clinical diagnosis47.295.977.887.175.5
Microscopy100100100100100
RDTs73.797.388.394.385.8

SN = sensitivity; SP = specificity; DA = diagnostic accuracy; PPV = positive predictive value; NPV = negative predictive value; and X2 = 10.150, Df = 4, and P value = 0.038 (P < 0.05).

4. Discussion

The only malaria parasite observed in this study was Plasmodium falciparum. This observation agreed with reports from some similar studies which identified only P. falciparum as the only malaria parasite present [12, 13]. According to the World Health Organization, P. falciparum is the most prevalent malaria parasite in most regions in Sub-Saharan Africa [14]. The overall malaria prevalence in this study using Giemsa microscopy as the gold standard was 43.1%. The study prevalence is comparable to 46.6% reported in Zamfara State [15], 40.8% in Rivers State [16], and 40.5% in South-Eastern Nigeria [17] but lower than 72.5% in Rivers State [18], 85.7% in Enugu State [19], and 71.4% in Cross River State [20]. The study prevalence (43.1%) is higher than 15.0% in Ogun State [21] and 14.7% in Lagos [22]. The prevalence of malaria in this study was significant and could be attributed to some environmental conditions such as temperature and humidity of the study area; Anopheles species thrive well in areas with warm temperature (25°C–28°C) and high relative humidity (90–100%) as well as lack of use of mosquito nets and blocked drainage facilities (which cause flooding and accumulation of stagnant water bodies during intense rainfall, thus increasing breeding and competence levels of Anopheles species). The sensitivity, specificity, and diagnostic accuracy recorded for clinical diagnosis was lower than those of RDT using microscopy as the diagnostic standard. There is need to review the use of clinical diagnosis due to its significant underdiagnosis recorded in this study, although some physicians in most malaria endemic regions claim that prompt treatment of suspected malaria cases (especially in children) reduces the progression of mild malaria to severe malaria. The continual usage of clinical diagnosis alone could have detrimental effects like drug abuse and malaria parasite resistance to antimalarials. RDTs were created to address some shortcomings of microscopy, and some previous similar studies reported low sensitivity (below 100 parasites/μL) and diagnostic accuracy for RDTs [23, 24] but data from this study showed that RDTs (if used and stored properly) had a significant higher sensitivity and diagnostic accuracy than clinical diagnosis. However, RDTs should be used to complement microscopy or alone when expert microscopy is unavailable especially in rural malaria, endemic areas of developing countries which lack well-equipped laboratories or expert microscopy for malaria diagnosis. It is vital to properly diagnose malaria especially in malaria-endemic regions, because it will help improve the diagnosis and treatment of other febrile (nonmalaria) infections and limit antimalarial usage to only malaria parasite-based test true positives. The findings from this study buttress the World Health Organization's policy that all clinical diagnosis must be confirmed by a laboratory parasite-based diagnosis before the administration of antimalarials to prevent malaria misdiagnosis and drug resistance.

5. Conclusion

Clinical diagnosis is not a reliable malaria diagnostic technique especially in Sub-Saharan Africa due to inadequate local epidemiological data on malaria and the presence of other febrile ailments which possess similar signs or symptoms with malaria. Therefore, all suspected malaria cases (clinical diagnosis) should be confirmed with a laboratory test.
  14 in total

1.  Challenges in routine implementation and quality control of rapid diagnostic tests for malaria--Rufiji District, Tanzania.

Authors:  Meredith L McMorrow; M Irene Masanja; Salim M K Abdulla; Elizeus Kahigwa; S Patrick Kachur
Journal:  Am J Trop Med Hyg       Date:  2008-09       Impact factor: 2.345

2.  Clinical algorithms for malaria diagnosis lack utility among people of different age groups.

Authors:  Tabitha W Mwangi; Mahfudh Mohammed; Hiza Dayo; Robert W Snow; Kevin Marsh
Journal:  Trop Med Int Health       Date:  2005-06       Impact factor: 2.622

3.  Malaria misdiagnosis: effects on the poor and vulnerable.

Authors:  Mark Amexo; Rachel Tolhurst; Guy Barnish; Imelda Bates
Journal:  Lancet       Date:  2004 Nov 20-26       Impact factor: 79.321

4.  Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission.

Authors:  B A Perkins; J R Zucker; J Otieno; H S Jafari; L Paxton; S C Redd; B L Nahlen; B Schwartz; A J Oloo; C Olango; S Gove; C C Campbell
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

5.  Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia.

Authors:  M W Weber; E K Mulholland; S Jaffar; H Troedsson; S Gove; B M Greenwood
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 6.  Update on rapid diagnostic testing for malaria.

Authors:  Clinton K Murray; Robert A Gasser; Alan J Magill; R Scott Miller
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Potential risk of induced malaria by blood transfusion in South-eastern Nigeria.

Authors:  Chigozie Jesse Uneke; Ogbonnaya Ogbu; Vincent Nwojiji
Journal:  Mcgill J Med       Date:  2006-01

8.  Malariometric Indices among Nigerian Children in a Rural Setting.

Authors:  Ekong E Udoh; Angela E Oyo-Ita; Friday A Odey; Komomo I Eyong; Chioma M Oringanje; Olabisi A Oduwole; Joseph U Okebe; Ekpereonne B Esu; Martin M Meremikwu; Asindi A Asindi
Journal:  Malar Res Treat       Date:  2013-02-28

9.  Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda.

Authors:  Daniel J Kyabayinze; James K Tibenderana; George W Odong; John B Rwakimari; Helen Counihan
Journal:  Malar J       Date:  2008-10-29       Impact factor: 2.979

10.  Assessment of Clinical Diagnosis, Microscopy, Rapid Diagnostic Tests, and Polymerase Chain Reaction in the Diagnosis of Plasmodium falciparum in Nigeria.

Authors:  Olusola Ojurongbe; Olunike Olayeni Adegbosin; Sunday Samuel Taiwo; Oyebode Armstrong Terry Alli; Olugbenga Adekunle Olowe; Taiwo Adetola Ojurongbe; Oloyede Samuel Bolaji; Oluwaseyi Adegboyega Adeyeba
Journal:  Malar Res Treat       Date:  2013-11-24
View more
  8 in total

Review 1.  Malaria diagnostic methods with the elimination goal in view.

Authors:  Olukunle O Oyegoke; Leah Maharaj; Oluwasegun P Akoniyon; Illiya Kwoji; Alexandra T Roux; Taiye S Adewumi; Rajendra Maharaj; Bolanle T Oyebola; Matthew A Adeleke; Moses Okpeku
Journal:  Parasitol Res       Date:  2022-04-23       Impact factor: 2.383

Review 2.  Malaria Rapid Diagnostic Tests: Literary Review and Recommendation for a Quality Assurance, Quality Control Algorithm.

Authors:  Michael J Kavanaugh; Steven E Azzam; David M Rockabrand
Journal:  Diagnostics (Basel)       Date:  2021-04-25

3.  Prevalence of Plasmodium falciparum field isolates with deletions in histidine-rich protein 2 and 3 genes in context with sub-Saharan Africa and India: a systematic review and meta-analysis.

Authors:  Loick P Kojom; Vineeta Singh
Journal:  Malar J       Date:  2020-01-28       Impact factor: 2.979

4.  Analysis of Epidemiological Changes and Prevention Effects for Malaria in Weifang, Shandong Province, China from 1957 to 2017.

Authors:  Xiao Song; Qiqi Shi; Chongxing Zhang; Xiangli Kong; Yeyuan Lv; Haifang Wang; Hongmei Liu; Lijuan Liu; Xiuxia Guo; Jingxuan Kou; Xiaodan Huang; Huaiwei Wang; Peng Cheng; Maoqing Gong
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

5.  The Role of Sex in Malaria-COVID19 Coinfection and Some Associated Factors in Rivers State, Nigeria.

Authors:  E O Onosakponome; M N Wogu
Journal:  J Parasitol Res       Date:  2020-12-02

6.  Plasmodium falciparum histidine-rich protein 2 and 3 genes deletion in global settings (2010-2021): a systematic review and meta-analysis.

Authors:  Ayalew Jejaw Zeleke; Asrat Hailu; Abebe Genetu Bayih; Migbaru Kefale; Ashenafi Tazebew Amare; Yalewayker Tegegne; Mulugeta Aemero
Journal:  Malar J       Date:  2022-01-29       Impact factor: 2.979

7.  Comparison of the performance of the CareStart Malaria Pf/Pan Combo test and field microscopy in the diagnosis of Plasmodium vivax malaria in North Sumatera, Indonesia.

Authors:  Ayodhia Pitaloka Pasaribu; Irma Sari Nasution; Krisnarta Sembiring; Fahmi Fahmi; Syahril Pasaribu
Journal:  Malar J       Date:  2022-01-29       Impact factor: 2.979

8.  Toward the Elimination of Malaria in China: A Retrospective Analysis of Malaria-Endemic Characteristics and Prevention Effects in Yantai, Shandong Province, 1951 to 2017.

Authors:  Xiao Song; Yang Wang; Xiangli Kong; Haifang Wang; Xiaodan Huang; Hongmei Liu; Lijuan Liu; Xiuxia Guo; Chongxing Zhang; Yuqiang Zhao; Jingxuan Kou; Huaiwei Wang; Peng Cheng; Maoqing Gong
Journal:  Vector Borne Zoonotic Dis       Date:  2019-10-29       Impact factor: 2.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.